Mutation screening of RET proto-oncogene in Chinese sporadic patients with pheochromocytoma.
- Author:
	        		
		        		
		        		
			        		Zhan-ying HAN
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Chun-guang QIU
			        		
			        		;
		        		
		        		
		        		
			        		Qing-hua CHEN
			        		
			        		;
		        		
		        		
		        		
			        		Yu ZHU
			        		
			        		;
		        		
		        		
		        		
			        		Ding-liang ZHU
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Journal Article
 - MeSH: Adrenal Gland Neoplasms; diagnosis; genetics; Adult; Asian Continental Ancestry Group; genetics; Base Sequence; China; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; genetics; Genetic Testing; Humans; Male; Middle Aged; Mutation; Pheochromocytoma; diagnosis; genetics; Polymerase Chain Reaction; Proto-Oncogene Proteins c-ret; genetics
 - From: Chinese Journal of Medical Genetics 2006;23(3):320-322
 - CountryChina
 - Language:Chinese
 - 
		        	Abstract:
			       	
			       		
				        
				        	
OBJECTIVETo screen the mutations of RET proto-oncogene in sporadic patients with pheochromocytoma.
METHODSForty-two cases of sporadic pheochromocytoma were tested for mutations of RET gene. Of these 42 DNA samples, 12 were extracted from peripheral blood cells and 30 from paraffin-embedded pheochromocytoma specimens. The PCR product of exon 10 and exon 11 was used to molecular analysis of the RET proto-oncogene.
RESULTSAmong 42 patients, 2 were found to have RET gene mutations. One of mutations located at codon 634 (TGC>TAC) in exon 11 of RET proto-oncogene. Another one located at codon 632 (GAG>AAG).
CONCLUSIONSome patients with apparently sporadic pheochromacytoma were carrier of mutations, a routine genetic analysis for mutations of RET gene is indicated for these patients.
 
            